Exclusive: Neuro startup Modulo Bio emerges to test small molecules for ALS, dementia

Embarking on a personal mission after his best friend’s mother was diagnosed with a mutation-driven case of frontotemporal dementia, Michael Horowitz has pulled together $8 million in venture funding at Modulo Bio to create small molecules for neurodegenerative diseases. The San Diego and Bay Area biotech will select its lead…